share_log

HC Wainwright & Co. Upgrades Alaunos Therapeutics to Buy, Announces $1.5 Price Target

HC Wainwright & Co. Upgrades Alaunos Therapeutics to Buy, Announces $1.5 Price Target

HC Wainwright & Co.將Alaunos Therapeutics升級爲買入,宣佈目標股價爲1.5美元
Benzinga ·  2023/05/15 07:21

HC Wainwright & Co. analyst Swayampakula Ramakanth upgrades Alaunos Therapeutics (NASDAQ:TCRT) from Neutral to Buy and announces $1.5 price target.

HC Wainwright & Co. 分析師Swayampakula Ramakanth將Alaunos Therapeutics(納斯達克股票代碼:TCRT)從中性上調至買入,並宣佈了1.5美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論